Fitzgerald Health Education Associates, Inc FHEA News Volume X, Issue IX September, 2010 Certification Question and Answer: What Types of Questions are on the NP Exams? by Margaret A. Fitzgerald DNP, FNP-BC, NP-C, FAANP, CSP Question: What kind of questions will I find on the NP certification exams? Response: The NP certification exams are comprised of multiple-choice questions; there are no true/false, fill-in-the-blank, essay or matching test items. Offer of the Month 10% off Dr. Stewart's NP program, School Based Behavioral Disorders in Children: Issues of Assessment and Intervention for the Primary Care Provider Upcoming NP Certification Exam Review Courses Question: Are all of the exam questions at the same level of complexity or difficulty? Response: Exam questions are written on a number of levels of difficulty and depth, with the lowest level usually the fact-oriented or knowledge questions. This type of question tests generalizations, principles and widely recognized theories. When answering the question below you might read the question and instantly recognize the correct answer from a piece of information that was memorized long ago. The following is an example of a fact-oriented question: Pupillary constriction in reaction to light is in part a function of cranial nerve: A) I. B) II. C) III. 2010 Schedule 09/10/2010 Oak Brook, IL 09/15/2010 Manhattan, NY 09/15/2010 Atlanta, GA 09/24/2010 Philadelphia, PA (Also Acute Care) 10/01/2010 Orlando, FL 11/05/2010 Kansas City, MO 11/11/2010 Dallas, TX 12/01/2010 Sacramento, CA 12/04/2010 Huntsville, AL 2011 Schedule D) IV. Correct answer- C (Continued on page 5) Fitzgerald Health Education Associates Catalog Available On-line! Browse through FHEA products and seminars in this convenient on-line format. Click here to visit the on-line catalog 01/04/2011 North Andover, MA 01/07/2011 Baltimore, MD 01/07/2011 Chicago, IL 01/11/2011 Atlanta, GA 01/14/2011 Oakland, CA 01/21/2011 Cleveland, OH 02/01/2011 Manhattan, NY 02/26/2011 Minneapolis, MN 03/11/2011 Charlotte, NC 03/17/2011 Philadelphia, PA 03/23/2011 San Diego, CA Click Here to See the Complete 2011 Schedule Take advantage of information and discounts available only to FHEA Facebook fans! Inside this issue: Benefits to Breastfeeding: A Review, by Marie Bosco 2 NCC Urges Healthcare Providers to Aid in Chlamydia Awareness, by Jaclyn Fitzgerald 2 Getting Ready For School: Food Allergy Emergency Action Plans, by Christy Yates 3 System Maintenance 3 Aphthous Stomatitis: Part 2, by Chris Steward 4 Special Offer 4 Contact Hour Tracker 4 New and Updated Products 5 Educational Travel 7 Margaret A. Fitzgerald’s Speaker School 8 Advanced Pathophysiology Course 9 Clinical Pharmacology Course 10 Need a Speaker? 13 Margaret Fitzgerald’s Upcoming Speaking Engagements 13 FHEA News Benefits to Breastfeeding: A Review by Marie L. Bosco, BSN, RNC, IBCLC Page 2 NCC Urges Healthcare Providers to Aid in Chlamydia Awareness by Jaclyn Fitzgerald, Assistant Editor The benefits of breastfeeding for both mother and child are numerous, but many of these benefits may be overlooked by mothers who are still deciding whether or not to breastfeed. The International Lactation Consultant Association consolidated recent studies that measure the valuable impact of breastfeeding on both mothers and their children. Benefits to the Child Include: 1. Reduced risk of adult obesity 2. Lower blood pressure 3. Reduced risk of osteoporosis 4. Improved lung function 5. Reduced risk of SIDS Benefits to the Mother Include: 1. Lower blood pressure 2. Less stress 3. Reduced risk of rheumatoid arthritis (women who breastfed for more than 13 months were half as likely to get rheumatoid arthritis) 4. Reduced risk of metabolic syndrome (women who breastfed for 9 months were less likely to be diagnosed during a 20 year study) 5. Reduced risk of cardiovascular disease (in post menopausal women, increased duration of lactation is linked to lower prevalence of HTN and cardiovascular disease) Breastfeeding rates continue to rise in the United States. With appropriate education and support, nursing mothers, their infants, and the country will reap the benefits of breastfeeding. This simple, organic, and “green” practice is the best choice for mothers and feeding infants. Integration of knowledge in healthcare practice will be beneficial not only to the health of mothers and their children, but to the health of the country as a whole. References: 10 More Reasons to Breastfeed. (2009). Retrieved August 10, 2010, from International Lactation Consultant Association: http://www.ilca.org/files/resources/ promotional_materials/10MoreReasons_BW_Bleed.pdf Since 2008, the National Chlamydia Coalition (NCC) has been making strides to increase awareness about the most widespread sexually transmitted bacterial infection in the United States, chlamydia, which is transmitted to an estimated 3 million people each year. The NCC was created when the Centers for Disease Control and Prevention aligned with Partnership for Prevention and various other healthcare organizations. The mission of NCC is to improve chlamydia screening rates by generating awareness about this infection among healthcare providers and the general public. Although chlamydia can be contracted by both sexes, it is exceptionally prevalent in sexually active women age 25 and younger. Despite the fact that the most common way of detecting chlamydia is by having a healthcare provider perform a simple urine or swab test, a mere 40% of young women are tested for this infection each year. Based on these numbers, healthcare professionals estimate that in addition to the 3 million people that are diagnosed with chlamydia each year, there are millions more who are undiagnosed because it is typically asymptomatic. An estimated 70% of females with chlamydia experience no symptoms at all. However, those who do experience symptoms will notice them within 1 to 3 weeks after exposure. Symptoms include dysuria as well as atypical vaginal or penile discharge; symptomatic women report dyspareunia. If left untreated in women, chlamydia can lead to pelvic inflammatory disease (PID), which often leads to infertility or ectopic pregnancy. Chlamydia can be treated with antibiotics and early treatment can reduce the risk of PID by 60%. The NCC recommends that healthcare providers offer screening for chlamydia at least once annually during office visits with men and women age 25 and younger, whether or not the office visit is for sexual health reasons. People over the age of 25 who have multiple sexual partners or who have had sexually transmitted infections before should also be tested regularly. Healthcare providers are urged to keep pamphlets about sexually transmitted infections in exam rooms so that patients can access this information privately. For additional information on NCC, please visit: http://ncc.prevent.org/index.html. For the NCC’s Implementation Guide for Healthcare Providers, please visit: http://ncc.prevent.org/download/4providers/WhyScreenFor Chlamydia_Web25.pdf. FHEA News Page 3 Getting Ready For School: Food Allergy Emergency Action Plans By Christy Yates, MSN, FNP-BC, NP-C, AE-C Family Allergy & Asthma Family Health Center Louisville, KY Senior Lecturer, Fitzgerald Health Education Associates, Inc. Christy Yates, MSN, FNP-BC, NP-C, AE-C This fall many children will be returning to school. For children with food allergies, healthcare providers often need to complete forms indicating what food(s) the child must avoid and what the emergency action plan will be if accidental ingestion occurs. Though forms vary somewhat across the country and even between school districts locally, they all ask the same type of questions. Some of these questions include the following: 2. What symptoms are most likely to be seen during an allergic reaction? Mouth itching, swelling of lips and/or tongue Throat* itching, tightness/closure, hoarseness, change in voice Skin itching, hives, redness, swelling of the face or extremities Stomach vomiting, diarrhea, abdominal cramps 1. What is the food the child must avoid? Lung* shortness of breath, coughing, wheezing 2. What symptoms are most likely to be seen during an allergic reaction? Heart* weak pulse, dizziness, passing out* 3. What medication(s) should be given if an allergic reaction occurs? *Symptoms can be life-threatening. ACT FAST! 4. Where should you keep the epinephrine autoinjector and who should administer the epinephrine? Remember: How would you answer these questions for Aiden, a 5year-old boy with a peanut allergy who is entering school this fall? This situation requires consideration of multiple factors. At age 1, Aiden experienced facial swelling, throat tightening, and hives on his face and neck immediately after eating a peanut butter cracker. His allergy skin prick testing revealed high IgE reactivity to peanut. His ImmunoCAP IgE to peanut was >100kU/L (>95% predictive of clinical reactivity). Considerations When Answering Questions for a Food Allergy Action Plan 1. What is the food the child must avoid? The child should avoid the food that caused the allergic reaction. In Aiden’s case, he must avoid peanuts. He is 5 years old now and it is highly unlikely he has “outgrown” his peanut allergy. Children are less likely to “outgrow” allergies to problematic foods such as peanuts, tree nuts, and seafood. This is particularly true if the initial level of allergen-specific IgE to a food is high, as was Aiden’s testing. Upon recheck, Aiden has continued to have a high level of allergen-specific IgE to peanuts and therefore needs to continue strict avoidance of them. Whether or not he should avoid all nuts is individualized and determined by the healthcare provider; prudent practice is to avoid all nut ingestion in order to avoid accidental allergen ingestion or contamination. ● Only a few symptoms can be present ● Severity can change quickly ● All of the symptoms can potentially progress to a lifethreatening situation. Aiden had facial swelling, throat tightening, and hives after eating peanut butter. To provide more detailed information to the school personnel regarding his allergic reaction, these symptoms can be highlighted. However, all symptoms, can be chosen since he, like other children, may have different symptoms with future reactions. 3. What medication(s) should be given if an allergic reaction occurs? Remember the most important medication in an anaphylactic reaction is epinephrine! (Continued on page 6) Notice of System Maintenance for Testing and Learning Site Routine maintenance is scheduled for September 18, 2010. FHEA is committed to providing our customers maximum uptime, reliability, and security for our On-line Testing and Learning Site. Regular system maintenance is critical to achieving this goal. System maintenance is normally performed the third Saturday of each month. FHEA News Page 4 Aphthous Stomatitis (Aphthous Ulcer)— Assessment and Treatment for the Nurse Practitioner: Part 2 By Christopher Steward, DMD, MA, FNP-BC Oral Surgeon and Family Nurse Practitioner Editor’s Note: The first half of this article focused on assessment of the aphthous ulcer. It was featured in the August edition of FHEA News. Click here to read Part 1. Treatment The first line in aphthous stomatitis therapy is minimizing or eliminating exposure to triggers. If lesions occur, a variety of therapies are helpful in minimizing discomfort and avoiding complications. Due to increased discomfort, oral hygiene is often comproChris Steward, mised because patients are sensitive to DMD, MA, FNP-BC brushing, flossing, and mouth rinses. The use of an antibacterial oral rinse such as PerioGard (chlorhexidine) oral rinse and a soft toothbrush can provide improved oral hygienes while minimizing tissue damage. Avoidance of toothpastes containing sodium lauryl sulfate is recommended as this may serve as an irritant to the eroded tissue; many even believe that this may even be a trigger in the initiation of the disease process itself. In severe cases, dehydration and malnutrition can occur due to poor oral intake; therefore, hydration status needs to be carefully monitored (Vincent, 1992). There are multiple nonsteroidal and topical corticosteroid treatment modalities. From my years of practice in general dentistry, oral surgery, and as a family nurse practitioner in treating these and other oral maladies, I have found the following routine to be effective. Have the patient rinse or swab the ulcer with chlorhexidine gluconate, 0.12% (available at Colgate PerioGard) to disinfect Special Offer: ECG Rhythm & 12-Lead ECG Interpretation These instructional tools start by teaching a systematic approach to assessing ECGs and expand to cover more complicated tracings. Package includes: — The Only EKG Book You'll Ever Need- Book — Cardiac Rhythms: A 5-Step Approach to Accurate Interpretation—CD-ROM — 12-Lead ECG Interpretation: A Primary Care Perspective— DVD — Beyond the Basics in 12-Lead ECG Interpretation—DVD Watch a preview here! Watch a preview here! Click here for more information and reduce the risk of any possible secondary infection(s) of the ulcerated area. The frequency of application depends upon the severity but will likely need to be administered 4 to 5 times per day. There is also a product known as Cora-Caine, a topical anesthetic in an adherent base, which the patient should apply onto the involved area in order to provide pain relief. Cora-Caine use is contraindicated in individuals with a history of allergy to the local anesthetics with the “-caine” suffix. This product can usually be purchased through a dental supply company or pharmacist and does not need a prescription. Apply this to the involved area 4 to 5 times per day after the mouth rinse. An excellent quick remedy and palliation for minor ulcers is amlexanox (Aphthasol®). It is in the form of an adherent paste that holds well to the oral mucosa. The strength is 5% and it comes in a 5 gram tube; adult dosing is 0.5 cm-1/4 inch. Place directly on ulcers 4 times a day following oral hygiene, after meals, and at bedtime. This is an excellent product to use after the PerioGard regiment listed above. It has a Category B pregnancy listing (Khandwala). For more aggressive recurrent or major aphthous ulcers, an excellent regimen is Kenalog® (triamcinolone 0.1%) in Orabase®, available in a 5 gram tube, which is also a paste and (Continued on page 7) Upcoming Suturing Conference The Art of Wound Repair— Suturing for NPs and PAs Instructor: Robert M. Blumm, MA, PA-C Location: New York, NY Date: February 2, 2011 Class hours: 8:30AM - 4:30PM Wound repair is a necessary skill for all NPs and PAs. It is usually placed into their academic curriculum with the knowledge that there will be an extensive period of practical application as they continue their studies and move forward into rotations. However, NPs and PAs graduate from their programs and pass their boards without acquiring this useful and billable skill. This workshop will be a full-day course with the utilization of a pig's foot, anesthesia tips, 4-0 nylon suture, a disposable stapler. Dermabond and other newer products about to come on the market will be covered, as an introduction to the use of a bio-adhesive in the care of lacerations. Click here for more information Page 5 FHEA News (Certification Question and Answer: Continued from page 1) Comment: Mnemonics or other memory aids can be helpful in answering a fact-oriented question. However, the certification exams will likely contain many more complex types of question that require application of clinical assessment and management skills. Examples of these include the comprehension question, where you must interpret the fact. An example of a comprehension question is as follows. The person with Bell palsy has paralysis of cranial nerve: A) V. B) VI. C) VII. D) VIII. Correct answer- C Comment: In order to respond correctly to this question, you must know that Bell palsy is a condition where the facial nerve (cranial nerve VII) is affected. Application questions are the most commonly found questions on the certification exam. For these questions you must analyze the information then decide what is pertinent to the given situation. Look for key words in the stem (the question itself) that help set a priority. These include words such as “first,” “initially,” or “most important action.” If you are having difficulty ascertaining which action should be done first, particularly when the question poses many plausible actions, you should ask yourself, “What is the greatest risk in this situation?” Here is an example. You are seeing Ms. Thomas, a 53-year-old woman who presents for a health exam. She smokes cigarettes with a 45 pack-year history, currently smoking 1.5 packs per day, and has a family history of premature heart disease. The most important part of her assessment is: stage is set for her to be at high risk for cardiovascular disease. Another assumption is that the best evaluation is one that picks up early disease. Now, look at the answers given and think what you may expect for results. In assessing Ms. Thomas, a chest x-ray could reveal lung cancer or findings consistent with tobacco-related lung disease. However, these changes will not be evident until these diseases are advanced; in earlier disease the chest x-ray is usually without specific findings. The presence of extra heart sounds would likely indicate systolic (S3) and/or diastolic (S4) cardiac dysfunction, again a marker of significant, usually advanced cardiac problems. However, blood pressure measurement is critical, as it can detect hypertension in its asymptomatic, earliest state; the presence of hypertension will significantly increase Ms. Thomas’s risk of heart disease. While screening for cervical neoplasia is important, diagnosing and intervening in hypertension would more likely improve this woman’s short-term health. After pulling together the facts, the best answer is clearly option C, blood pressure measurement. Comment: A multiple-choice question has a number of components. Often, the first sentence is an introduction of a clinical scenario. Here is an example of a rather lengthy introduction, rich with information. You see 18-year-old Sam who was seen approximately 36 hours ago at a local walk-in center for treatment of ear pain. Diagnosed with (L) acute otitis media, amoxicillin was prescribed. Today, Sam states that he has taken 5 amoxicillin doses since the medication was prescribed but continues to have discomfort in the affected ear. Left TM is red and immobile. He is without fever and denies GI distress or other symptoms. (Continued on page 11) New and Updated Products A) Chest x-ray. Griffith's Instructions for Patients, 8th Edition B) Auscultation for S3 and S4 heart sounds. With more than 430 patient instruction fact sheets on topics from abruption placentae to zinc deficiency, and an additional 123 patient instruction sheets online, the new edition of Griffith's Instructions for Patients by Stephen W. Moore, MD, helps patients understand what their illness is, how it will affect their regular routine, what self care is required, and when to call a doctor. Click here for more information C) Blood pressure measurement. D) Cervical examination with Pap testing. Comment: When looking at this question, you may be struck with the fact that you would certainly perform a cardiac exam and Pap test. With the limited amount of information available on this patient, no indication for chest x-ray is evident. So, how do you set the priority of the most important part of the assessment? Start with teasing out the facts and assumptions. In the information presented, Ms. Thomas has two clearly apparent risk factors for cardiovascular disease, cigarette smoking and family history of premature heart disease Assume she is postmenopausal, since the average woman reaches this stage by age 51 years. This gives her an additional cardiovascular risk factor. In addition, heart disease is the leading cause of death in American women. Thus, the Physical Assessment & Health History of the Child Cue Cards, 7th Edition The Physical Assessment & Health History Cue Cards will help guide you through the process of performing and verbalizing findings on a comprehensive child exam in addition to taking a comprehensive child health history. Click here for more information FHEA News Page 6 (Getting Ready for School: Continued from page 3) Epinephrine EpiPen Jr® 0.15 mg IM or SC 33-66 lbs (~15-30 kg) EpiPen ® 0.30 mg IM or SC >66 lbs (~ 30 kg) TwinJect® 0.15 mg IM or SC 0.30 mg IM or SC 33-66 lbs (~15-30 kg) >66 lbs (~ 30 kg) Adrenaclick® 0.15 mg IM or SC 0.30 mg IM or SC 33-66 lbs (~15-30 kg) >66 lbs (~ 30 kg) Epinephrine auto-injector (generic) 0.15 mg IM or SC 33-66 lbs (~15-30 kg) 0.30 mg IM or SC >66 lbs (~ 30 kg) this needed information. Another consideration is legislation regarding the management of food allergies in schools in your area (for more information visit: www.foodallergy.org/page/legislation).Virtually every state has passed legislation allowing students, with appropriate consent, to carry their epinephrine. But these laws vary in terms of whether this permission extends to school activities outside of the school building. If school personnel will be administering emergency medication, then it will be kept either in the classroom, with an adult (usually a teacher) and carried throughout the day, or in the school office. Regardless of the location, the emergency medication must be close and easily accessible. The personnel administering the medication must be trained to recognize signs and symptoms of an acute allergic reaction/anaphylaxis, and must know the proper use of epinephrine autoinjectors. Getting the parents’ input is also important. *IM preferred over SC *May repeat in 5-10 minutes if needed Antihistamine: Diphenhydramine (Benadryl) 1-2 mg/kg orally (maximum dose= 50 mg) Other: Albuterol MDI 2 puffs; repeat every 20 minutes x 3 if difficulty breathing, chest tightness, wheezing, and/or cough is present As consistent with many 5-year-old children, Aiden was not yet ready to self-administer and/or keep track of the epinephrine injector at school. Therefore, the best choice for Aiden was to keep the injector in the classroom. When he changes rooms, and when he goes to lunch and plays outside or in the gym, the auto-injector is easily accessible. The teacher is well educated on food allergies and has demonstrated proper technique of the epinephrine auto-injector. There is no certain age in which a child can selfadminister the injection. Most children can use it properly and responsibly in middle-school, but it is highly variable and dependent on many factors. For Aiden, his plan of care includes: (1) Epinephrine via auto-injector (EpiPen®), 0.30 mg IM to the outer thigh (may repeat in 5 to 10 minutes if needed) (2) Diphenhydramine (Benadryl) 12.5 mg/5ml; 10 ml (3) Albuterol (ProAir) MDI 2 puffs and may repeat every 20 minutes x 3 if he is having difficulty breathing, has chest tightness, wheezing, and/or cough Action If the child is exhibiting any signs of anaphylaxis do not hesitate to give epinephrine and call 911! Notify school personnel trained in CPR/first aid Notify parent(s) 4. Where should you keep the epinephrine autoinjector and who should administer it? The location depends on who is going to administer the injection. If the student is going to self-administer the epinephrine, then the student must be responsible enough to be in possession of the medication during the school day, field trips, and all extracurricular activities. Obtaining parental input is important to determine if the child can do this. In addition to being responsible and having the skills to administer the injection, the child’s emotional maturity needs to be considered. How likely is it the child will panic during an emergency and be too scared to self-administer the injection, or do it incorrectly? The parents can provide Epinephrine Auto-injector Clinical Pearls Using a demonstrator, teach children, parents, and school personnel how to use the auto-injectors. Have them return the demonstration so they feel comfortable with the device. Ask hypothetical questions to children to assess their level of understanding regarding emergencies, epinephrine use, and to assess their emotional readiness to handle emergencies. Examples of questions include: ● If you were outside playing at school and had just eaten lunch, and you started itching, your throat was getting tight and you were having trouble breathing, what would you do? ● What do you think made you feel this way? ● Would you be nervous about giving yourself a shot (or someone else giving it to you)? (Continued on page 12) FHEA News Page 7 (Aphthous Stomatitis: Continued from page 4) should be used after meticulous PerioGard oral hygienes. Advise the patient to apply about a 1/4" ribbon to the lesion. Instruct the patient to dab it on the lesion just enough to get off the finger and onto the lesion; the product is pregnancy risk factor category C, as are all topical corticosteroids. Another economical remedy that is an excellent over-thecounter product and should be kept in any dental/medical office is Debacterol® manufactured by EPIEN Medical, Inc. This is a cauterization product that contains 50% sulfonated phenolics, 30% sulfuric acid, and water. This product gives the patient instant relief complete resolution of the area in 3 to 5 days. Continued debridement with PerioGard prior to use of this product is recommended. The patient can purchase Debacterol®, but in the majority of minor or even some major aphthae, only one treatment is needed. When using this product, it is critical that a proper diagnosis be made to ensure that you are treating an aphthous ulcer and not a vesicular lesion such as herpes simplex type 1 or 2 (Rhodus, 1998). In severe or persistent cases, other immunomodulators, including thalidomide in variable doses (50 to 300 mg/day) have shown efficacy; however, thalidomide has an X pregnancy risk factor and should never be used in females. Thalidomide (Thalomid) is a known teratogen; effective contraception must be used for at least 4 weeks before initiating therapy, during therapy, and for 4 weeks following discontinuation of thalidomide for women of childbearing potential. Educational Travel Update on Events for 2011 By Marc W. Comstock, CEO Fitzgerald Health Education Associates, Inc. Upcoming Course Location Sheraton Maui Resort and Spa, Lahaina, HI March 15 and 16, 2011 8:00 a.m. to 1:00 p.m. Due to the overwhelming success of the Pharmacology Update in Maui in March of this year, FHEA is offering the 2011 version of this seminar on Maui’s Ka’anapali beach at the Sheraton Maui Resort & Spa. Be sure to book your air and hotel reservations early as this is a very busy season in Hawaii! Featuring: ● The latest in treatment options ● In-depth pharmacologic information on clinical conditions you encounter in practice There are several “Magic Mouthwash” recipes available. The Prescribers Newsletter provides a number of the more common mixtures. Personally, I vary these depending on the severity of the lesion and anticipated patient compliance. Avoid tetracycline use when treating pregnant women and children. The first mixture listed below is more palatable and tends to have greater patient compliance. A pharmacist can also flavor the mix to mask some of the taste and smell if the patient finds it offensive. Magic Mouthwash Recipes Option 1: Ingredients Amount Diphenhydramine (Benadryl) 12.5mg/mL 240 ml Hydrocortisone 60 mg Nystatin Powder 6 million units Tetracycline 1.5 g Maalox or Mylanta 80 ml Sig: Swish and spit 5 ml QID Option 2: Ingredients Amount Viscous lidocaine 2% 80 ml Mylanta or Maalox (magnesium, aluminum hydroxide, simethicone) Diphenhydramine 12.5 mg/5 mL 80 ml 80 ml Nystatin suspension 80 ml Prednisolone 15 mg/5ml 80 ml Distilled water 80 ml Sig: Swish, gargle and swallow to 10 ml Q6H Option 3: (A great mouth rinse for oncology patients) Ingredients Amount Diphenhydramine 12.5 mg/5 mL 1 part Viscous lidocaine 2% 1 part Maalox or Mylanta 1 part Sig: Swish and swallow 5 mL no more than QID. Click here for more information (Continued on page 8) FHEA News Page 8 (Aphthous Stomatitis: Continued from page 7) A topical corticosteroid suspension recipe is as follows: ● Triamcinolone acetonide 0.1% aqueous suspension, Disp 200 ml, Sig 5 ml oral rinse and expectorate after meals and at bedtime. Do not eat or drink for 1 hour after using. (Directions to the Pharmacist: Injectable triamcinolone QS into water for irrigation, add 5 ml of ethanol to increase solubility) May alter suspension to include viscous lidocaine as a topical anesthetic. Note: The most common complication/side effect of long-term topical triamcinolone use is oral candidiasis. In these cases, an antifungal such as nystatin can be used in the topical triamcinolone suspension (replacing the water). When the aforementioned therapies are not sufficient, consultation with an oral-maxillofacial surgeon should be considered. Additional therapeutic options include a prednisone burst (40 mg q.d. in the morning 30 minutes after arising for 5 days, then 20 mg q.o.d. also 30 minutes after arising for an additional 1 to 2 weeks), and dapsone, colchicine, and azathioprine (Imuran). Evaluate for signs of secondary infection around the initial lesion on the nonkeratinized tissue. If these regimens do not bring considerable relief to the patient then inquiry should be made about family history of systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), or Behçet disease. The following labs should then be considered: Complete blood count, rapid plasma reagin test, antinuclear antibody, Tzanck stain (herpes virus), celiac disease serology, evaluation of HIV status and micronutrient deficiency test focused on vitamins B6 and B12, serum iron and folate. References Khandwala A, Van Inwegen RG, Charney MR, et al., “5% Amlexanox Oral Paste, A New Treatment for Recurrent Minor Aphthous Ulcers: II. Pharmacokinetics and Demonstration of Clinical Safety,” Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1997, 83(2):231-8. Porter SR, Scully Cbe C. Aphthous ulcers (recurrent). Clin Evid (Online). 2007;2007. Product information for First Mouthwash BLM. Cutis Pharmaceutical. Woburn, MA 01801. February 2008. Regezi RA, Sciubba JJ, Jordon, CK: Oral Pathology, Clinical Pathologic Correlations, ppg. 36-38, 2008 Rhodus, N.L, Quintessence Int. 1998 Dec; 29(12):769-73. The Erie St. Clair Palliative Care Management Tool. January 2007. http://www.ccacont.ca/Upload/esc/General/Palliative_Care_Managment_Tool_v3. 2.pdf (accessed October 11, 2009). Vincent SD, Lilly GE: Clinical, historic and therapeutic features of aphthous stomatitis. Oral Surg Oral Med Oral Path, 74:79-86, 1992. “Magic Mouthwash Recipes,” The Prescribers Newsletter (July 2007; Vol: 14(7):230703). Study with a Master Dr. Margaret A. Fitzgerald's Speaker School Fitzgerald Health Education Associates Conference Center 85 Flagship Dr, North Andover, MA 01845 March 3–4, 2011 Earn 14 Contact Hours! If you have ever wanted to share your practice expertise by speaking to other providers, or if you just want to improve your "platform skills," this is the seminar for you! This two-day intensive workshop will be led by Dr. Margaret Fitzgerald, one of the most experienced, well-known, and skilled NP speakers in the country. With more than one thousand presentations to her credit, she has been recognized by the NP community for her dynamic speaking abilities. Dr. Margaret Fitzgerald also earned the coveted Certified Speaking Professional (CSP) designation from the National Speakers Association. Dr. Margaret A. Fitzgerald's Speaker School will make extensive use of recorded practice presentations prepared by participants, recorded in the FHEA studio, and critiqued by instructors and peers. Hands-on presentation preparation and slide development techniques will be covered. Also learn how to improve your "speaking voice." The workshop is limited to twenty participants. A personal laptop equipped with Microsoft PowerPoint will be required. Click here for more information FHEA News Page 9 5 ¾ Day Advanced Pathophysiology for NPs and Advanced Practice Clinicians Manhattan, NY July 18-23, 2011 More Information Here Presented by: Sally K. Miller, PhD, ACNP-BC, ANP-BC, FNP-BC, GNP-BC, CNE, FAANP Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP Earn 45 Contact Hours! Presented by highly acclaimed clinician-educators who currently maintain clinical practice, thus bringing clinical relevance to the classroom in addition to their knowledge and teaching skills in pathophysiology. FHEA instructors consistently rank at the top of speaker ratings at national conferences. Both the course material and testing material are kept up-to-date on subject matter. The electronic components of this program are updated as needed to reflect the current state of practice. Test items are professionally developed and are subject to rigorous validity and reliability review. Meets the needs of a geographically dispersed student population using on-line lectures with full audio-visual content. On-line version allows students to proceed at their own pace and earn contact hours as they complete each module. Topics Presented by Sally K. Miller Unit I Cellular Pathophysiology I. Cell structure and function II. Mechanisms of cellular transport III. Membrane and action potentials Unit III Mechanisms of Cell Trauma I. Reversible injury II. Irreversible injury III. Hypoxia IV. Physical trauma V. Infectious trauma VI. Chemical trauma Unit IV Cellular Response to Injury I. Adaptation II. Inflammation Unit V Pathophysiology of the Hematologic System I. Hematopoiesis II. Microcytic anemias III. Macrocytic anemias IV. Hemoglobinopathies V. Primary hemostasis VI. Secondary hemostasis Unit VI Pathophysiology of the Nervous System I. Synaptic transmission II. Neurotransmitter III. Post-synaptic processes IV. Selected disorders Unit VIII Pathophysiology of the Cardiovascular System I. Cardiac action potential II. Contractile tissue III. Non-contractile tissue IV. Cardiac conduction V. Contractile fibers and the sarcomere VI. Electromechanical coupling VII. Cardiac muscle tasks VIII. Selected disorders IX. Lipid synthesis and transport X. Selected dyslipidemias Unit IX Pathophysiology of Endocrine Disease I. Types of hormones II. Hormone receptors III. Feedback mechanisms of secretion IV. Maintenance of plasma glucose concentration V. Maintenance of thyroid hormone concentration VI. Maintenance of adrenal cortex/ medullary hormone concentration VII. Selected disorders Unit X Pathophysiology of Pulmonary Disease I. Anatomy and physiology of airways II. Vascular and lymphatic anatomy III. Autonomic nervous system regulation IV. Compliance and recoil V. Airflow and resistance VI. Ventilation and perfusion VII. Selected obstructive/restrictive diseases Unit XI - Pathophysiology of Renal Disease I. Anatomy and physiology of the nephron II. Regulation of blood pressure, calcium, and erythropoietin III. Regulation of renal function; tubuglomerular feedback IV. Cortical and medullary flow V. Acute renal failure VI. Chronic kidney disease VII. Electrolyte imbalance VIII. Regulation of acid/base balance Unit XII - Pathophysiology of Digestive System Disease I. Anatomy and musculature of the gastrointestinal track II. Neural control systems III. Chemical control systems IV. Myogenic control systems V. Oropharyngeal/esophageal motility VI. Gastric motility and control VII. Gastric acid secretion VIII. Selected disease states Topics Presented by Margaret A. Fitzgerald Unit VII - Pathophysiology in Reproduction I. Factors influencing impaired female fertility II. Factors influencing impaired male infertility III. Pathophysiologic problems encountered in pregnancy: Recurrent pregnancy loss, pregnancy induced hypertension, placental disorders, others Click here for more information about this course FHEA News Page 10 5 ¾ Day Clinical Pharmacology for NPs and Advanced Practice Clinicians Presented by: Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP and Sally K. Miller, PhD, ACNP-BC, ANP-BC, FNP-BC, GNP-BC, CNE, FAANP Presented live in the following cities: Topics covered in this course: Atlanta, GA— October 27 to November 1, 2010 Manhattan, NY—February 14 to 19, 2011 National legal and practice issues. Dallas, TX— October 25 to 30, 2011 Principles of safe prescribing: Pharmacokinetics, pharmacodynamics, pharmacogenomics, drug interactions. Prescribing in special populations: Pregnancy, lactation, children, older adults. Hormonal contraception and post menopausal hormone therapy. Pharmacologic management in type 1 and type 2 DM: Oral agents, insulin and non-insulin preparations. Principles of antimicrobial therapy: Intervention in bacterial infection. Drugs that affect the respiratory system: Beta2 agonists, methylxanthines, anticholinergics, mast cell stabilizers, inhaled and systemic corticosteroids, leukotriene modifiers, over-the-counter cough and cold medications. Evaluation and intervention in common thyroid disorders. Assessment and intervention in common anemias. Drugs that affect the cardiovascular systems: Antihypertensives, antianginals, dysrhythmics, medications used in the management of heart failure. Pharmacologic treatment of lipid abnormalities and drugs that affect clotting. Drugs that affect the GI system: H2 receptor antagonists, proton pump inhibitors, antacids, prokinetics, antidiarrheals, including over-the-counter medications. Management of viral, fungal and protozoal infection. Management of pain; opioids, NSAIDs and others including over-the-counter medications. Management of eye, ear, and skin disorders. Can’t attend a live course? This program is also available on-line* Click here for more information This course addresses the growing need for a thorough course in the principles of pharmacotherapeutics. Prescribing has become a major part of the role of advanced practice nurses while at the same time, prescribing has become more complex and polypharmacy is more prevalent with the possibility of adverse interactions. Thus, a course of this caliber is critical to the preparation of advanced practice nurses. The course is taught in an intensive format by two of the nation’s most respected NP educators. The instructors have taught this curriculum at several universities most recently at Pennsylvania State, Pace University, Neumann College, Georgia College and State University. In addition, recorded lectures of this course form the basis for other university NP pharmacology courses. The material constitutes the equivalent of a three credit university course in pharmacology. Pharmacology contact hours: 45.0** Code: PCON — standard $799; advance: $7501; early bird: $6992 Note 1: Registrations received or postmarked between two months and two weeks prior to the start of the course qualify for this rate. Note 2: Registrations received or postmarked more than two months prior to the start date of the course qualify for this rate. Upon receipt of your enrollment and full payment, you will receive a confirmation of registration and directions to the course. A fee of $50.00 will be charged for cancellation. No refunds will be granted within two weeks of the starting date. All cancellations and changes must be received in writing. * Contact hours differ from the live course. See www.fhea.biz for details. **Because states’ requirements vary, it is important that you contact your Board for details regarding educational requirements for prescriptive authority. For more information visit: www.fhea.biz FHEA News Page 11 (Continued from page 5) When responding to this question, remember that test questions are designed to have one best, though perhaps not perfect, answer. In clinical practice, you would likely gather more information than is given here. During the certification examination you have to decide on the best response given the information presented while applying sound clinical judgment. Here are the clinical points as they relate to this particular question. Consider the following: As inflammation and purulent exudate forms in the middle ear, a small space rich with pain receptors, otalgia is an expected finding in AOM. This usually resolves after 2 to 3 days of antimicrobial therapy. Tympanic membrane immobility is a cardinal sign of AOM that in spite of antimicrobial therapy does not resolve for a number of weeks. Patient report of otalgia is also needed to make the AOM diagnosis. The next part is the statement that poses the question to be answered. Since no chronic health problems are mentioned, assume Sam is a young adult who is typically in good health. Acute otitis media (AOM) is common episodic illness usually caused by S. pneumoniae, H. influenzae, M. catarrhalis or respiratory virus. One of the first-line antimicrobials for AOM treatment is amoxicillin. When given in an adequate dose, this antibiotic is effective against S. pneumoniae, and non-betalactamase producing H. influenzae and M. catarrhalis. Nearly all M. catarrhalis and about 30% of H. influenzae produce beta-lactamase, rendering amoxicillin ineffective. Clavulanate is a beta-lactamase inhibitor and when given in conjunction with amoxicillin is an effective treatment option when AOM fails to respond to amoxicillin alone. A) Advise Sam to discontinue the current antimicrobial and start course of amoxicillin with clavulanate. 12th ANNUAL B) Perform tympanocentesis and send a sample of the exudate for culture and sensitivity. Iowa Nurse Practitioner Society Conference presented by: Iowa Nurse Practitioner Society Location: The Marriott at West Des Moines Hotel 1250 Jordan Creek Drive Des Moines, IA 50266 Dates: November 3-5, 2010 Purpose: This CEU program is designed to provide ARNPs with the latest information related to a variety of practice settings. Objectives: 1. Understand current and evolving information in health care 2. Identify concepts relevant to Individual practice 3. Interact with Iowa NPs to promote relationship building Your next best action is to: This is an action-oriented question, directing you to consider Sam’s care and chief complaint. Choosing this response infers amoxicillin treatment failure. However, AOM antimicrobial treatment failure is usually defined as persistent otalgia with fever after 72 hours of therapy. Sam has taken less than 2 days of therapy; too short an interval to assign continued symptoms to ineffective antimicrobial therapy. AOM antimicrobial therapy is based on choosing an agent with activity against the most likely organisms, bearing in mind the most common resistant pathogens. Tympanocentesis is indicated only with treatment failure after 10 to 21 days of antimicrobial therapy with a second-line agent, with the goal of detecting a significantly resistant organism; at that point, culture and sensitivity of middle ear exudate would be appropriate. With less than 2 days of treatment, tympanocentesis is not indicated. C) Have Sam return in 24 hours for reevaluation. Certainly, if Sam’s condition worsens in the next day, reevaluation is prudent; however, choosing this option ignores Sam’s complaint of pain. D) Recommend that Sam take ibuprofen for the next 2 to 3 days. Choosing option D infers that treating Sam’s pain is the most appropriate intervention. This is the best response and therefore the correct answer. The highlights of the conference include, exciting PreConference Boot Camps in 3 specialty areas. A variety of breakout sessions will appeal to all specialties. The Fitzgerald Nurse Practitioner Certification Exam Review and Advanced Practice Update has helped more than 55,000 NPs nationwide achieve certification and improve their clinical assessment skills since its inception in 1988. Fitzgerald Health Education Associates is the nation's leading provider of certification preparation. Registration is available online at: http://www.iowanpsociety.org Click here for more information Keynote Speaker: Wendy Wright will be presenting updates on drug changes and malpractice. Page 12 FHEA News (Getting Ready for School: Continued from page 6) ● Where is your epinephrine shot now? ● Show me how you would use it if you would need it (use a demonstrator). Check the expiration date; often the child’s epinephrine auto-injector has expired. The expiration date is usually one year from purchase. Do not change the type of autoinjector without making sure the patient, parent(s), and/or school personnel know how to use the different brand. These devices differ a bit. If you demonstrated how to use one type of injector, and the child receives a different type at the pharmacy, the child, family, and caregivers might not know how to use it. With the recent release of the generic epinephrine auto-injector, a pharmacy could give the patient a different version than was written on the prescription. Being Proactive: Clinical Pearls for Parents of a Child with Food Allergy ● Communicate to teachers and other school personnel that your child has a food allergy and the emergency plan. ● Encourage your child to take on more age-appropriate responsibility for their safety. ● Have your child wear a medical alert bracelet. ● Encourage epinephrine auto-injectors be kept in classrooms, the school office, and the cafeteria. ● Consider prescribing two-pack epinephrine autoinjectors in order to have an additional injection in case it is needed and/or to have the second injector at home. The two-pack prescription is usually available for the same co-pay as the single auto-injector. Investigate coverage for a two-pack, dispense #2 prescription for four auto-injectors if a child goes to multiple locations. As always, consider the child’s risk and individualize the plan. ● ● Purchase a hard plastic, puncture-proof case for the auto-injector to avoid accidental exposure and injection. The Food Allergy & Anaphylaxis Network (FAAN) (available at: www.foodallergy.org) provides resources for the many styles available on the market. Utilize resources, such as the Food Allergy and Anaphylaxis Network. Food Allergy Facts The prevalence of food allergies as perceived by the public is 12to 13%, with some studies reporting as high as 25%. The prevalence as confirmed by healthcare providers in children is 6%. Eight foods account for 90% of all food allergic reactions in the U.S: milk, eggs, peanuts, tree nuts, wheat, soy, fish, and shellfish. Peanuts, tree nuts, fish and shellfish are responsible for the majority of severe allergic reactions/anaphylaxis. Fatal Food-Induced Anaphylaxis Prevalence 100 to 200 deaths per year in the United States Risk factors Symptom denial Delayed epinephrine administration Underlying asthma Previous severe reaction Adolescents History Ingestion of a known allergen Key foods Peanut and tree nuts (approximately 90% fatalities), fish, and shellfish Location Most occurred away from home Clinical features Respiratory symptoms were prominent Cutaneous symptoms may be absent Biphasic reaction may contribute to the problem For additional resources and examples of food allergy action plans, visit the links below: http://www.foodallergy.org/files/FAAP.pdf http://www.aaaai.org/members/resources/anaphylaxis_too lkit/action_plan.pdf References: Chapman, J., Bernstein, L. et al. Food Allergy: A practice parameter. Ann Allergy Asthma Immunol. 2006;2006: Vol 96. Accessed on July 1, 2010 from http://allergyparameters.org/file_depot/010000000/3000040000/30326/folder/73825/2006%20Food%20Allergy Food allergy education for health professionals. Food Allergy & Anaphylaxis Network. Accessed June 30, 2010 from http://www.foodallergy.org/section/for-health-professionals1 Lieberman, P. & Kemp, S., et al. The diagnosis and management of anaphylaxis: An updated practice parameter. Joint Task Force on Practice Parameters. J Allergy Clin Immunol.2005;115:S483:S23. Accessed July 1, 2010 from http://www.aaaai.org/professionals/resources/pdf/anaphylaxis_200 5.pdf. Additional information available at: Adrenaclick website: www.Adrenaclick.com, accessed July 2, 2010 EpiPen website: www.EpiPen.com, accessed July 2, 2010 Twinject website: www.TwinJect.com, accessed July 2, 2010 Fitzgerald Health Education Associates, Inc. FHEA News 85 Flagship Drive, North Andover, MA 01845-6154 Phone: 978.794.8366 Fax: 978.794.2455 E-mail: [email protected] Need a Speaker? If you are interested in having Dr. Fitzgerald or one of our other talented associates speak at your school, local, regional or national conference, please e-mail: [email protected] for more information. Conference administrative services are also available. Providing Education to the Healthcare Community Interested in advertising in this newsletter? Email [email protected] Editorial Staff Dr. Margaret Fitzgerald’s Upcoming Speaking Engagements Date Managing Editor: Marc Comstock Editor: Emily Paquin September 9, 2010 Click here for more information September 15, 2010 Nurse Practitioner Certification Exam Review and Advanced Practice Update DoubleTree Atlanta Buckhead 3342 Peachtree Road NE Atlanta, GA Click here for more information September 18, 2010 8th Annual Central Georgia United Advanced Practice Registered Nurses Fall Seminar Hanger One—Museum of Aviation Hwy. 247 & Russell Pkwy. Warner Robins, GA Click here for more information October 1, 2010 33rd Annual Nurse Practitioners of Oregon Education Conference Salishan Spa & Golf Resort 7760 Highway 101 North Gleneden Beach, OR Click here for more information October 27, 2010 Clinical Pharmacology for NPs & Advanced Practice Clinicians DoubleTree Atlanta Buckhead 3342 Peachtree Road NE Atlanta, GA Click here for more information November 11, 2010 Nurse Practitioner Certification Exam Review and Advanced Practice Update InterContinental Dallas 15201 Dallas Parkway Addison, TX Click here for more information December 1, 2010 Nurse Practitioner Certification Exam Review and Advanced Practice Update Sacramento, CA Click here for more information Contributors Margaret A. Fitzgerald DNP, FNP-BC, NP-C, FAANP, CSP Marie L. Bosco, BSN, RNC, IBCLC Open Forum FHEA welcomes articles, news, comments and ideas from its readers! Please e-mail [email protected] If you would like to contact customer service please email [email protected] We have sent this e-mail newsletter in the hope that you will find it useful. If you prefer not to receive future issues, please e-mail: [email protected] Please include "Stop" as the subject of your e-mail and your full name and the mail address you wish to cancel in the body. If you received a copy of this newsletter from a friend, you can subscribe by sending an e-mail to: [email protected]. Be sure to include your full name, mailing address and daytime phone number so that we can confirm and authenticate your subscription. Topics Nurse Practitioners of Idaho Conference Owyhee Plaza 1109 Main St. Boise, ID Assistant Editors: June Kuznicki Jaclyn Fitzgerald Technical Assistant: Bernice Flete Location
© Copyright 2024